Schroder Investment Management Group Boosts Stake in ResMed Inc.

The institutional investor increased its holdings in the medical equipment provider by 6% during the third quarter.

Mar. 12, 2026 at 10:09am

Got story updates? Submit your updates here. ›

Schroder Investment Management Group increased its stake in ResMed Inc. (NYSE:RMD) by 6.0% during the 3rd quarter, according to the company's recent Form 13F filing with the Securities and Exchange Commission. The institutional investor now owns 155,188 shares of the medical equipment provider's stock, valued at approximately $42,064,000.

Why it matters

ResMed is a leading global provider of medical devices and cloud-connected solutions for sleep apnea and other respiratory conditions. The increase in Schroder's stake suggests the investment firm sees continued growth potential in the company as it expands its product offerings and market share.

The details

Schroder Investment Management Group acquired an additional 8,738 shares of ResMed during the third quarter, bringing its total holdings to 155,188 shares. This represents approximately 0.11% of ResMed's outstanding stock. The purchase was part of Schroder's broader strategy to increase its exposure to the medical technology sector, which it sees as a growth area.

  • Schroder Investment Management Group increased its stake in ResMed during the 3rd quarter of 2026.

The players

Schroder Investment Management Group

A global asset management firm that provides investment products and services to institutional and retail clients worldwide.

ResMed Inc.

An American medical device company that develops, manufactures, and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

Schroder's increased stake in ResMed suggests the investment firm sees continued growth potential in the medical device company as it expands its product offerings and market share in the sleep apnea and respiratory care markets.